Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:52:08.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:52:18.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study criteria and descriptions for a clinical trial comparing pembrolizumab and methotrexate for head and neck cancer, while retaining some key terms and study identifiers.
    Difference
    42%
    Check dated 2025-04-16T01:48:27.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:24:04.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:16:46.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:32:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.